Categories
Archives
- 2026
- 2025
- 2024
- 2023
Sep
09
UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA® (certolizumab pegol) in pregnant women with antiphospholipid syndrome (APS)
Aug
31
UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing
Aug
16
Axios Names UCB a Winner of the Metro Atlanta Top Workplaces 2026 Award
Aug
05
Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome
Jul
07
UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S.
Jun
17
UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI® (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)
Jun
04
Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps
Jun
03
Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis
Jun
01
UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa and Immediate Family Members